Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial

Journal:
Nature Medicine
Published:
Affiliations:
32
Authors:
33
Institutions Authors Share
Brii Biosciences - China, China
4.000000
0.12
Brii Biosciences, United States of America (USA)
3.000000
0.09
The Chinese University of Hong Kong (CUHK), China
1.000000
0.03
The University of Hong Kong (HKU), China
1.000000
0.03
The Third Affiliated Hospital, SYSU, China
1.000000
0.03
The Second Affiliated Hospital of Chongqing Medical University, CQMU, China
1.000000
0.03
Ruijin Hospital, SJTU, China
1.000000
0.03
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China
1.000000
0.03
Kyungpook National University Hospital (KNUH), KNU, South Korea
1.000000
0.03
Maharaj Nakorn Chiang Mai Hospital, CMU, Thailand
1.000000
0.03
Chuncheon Sacred Heart Hospital, HUMC, South Korea
1.000000
0.03
Chulalongkorn University (CU), Thailand
1.000000
0.03
Asan Medical Center (AMC), South Korea
1.000000
0.03
Sunshine Coast University Hospital, Australia
1.000000
0.03
Nepean Hospital, USYD, Australia
1.000000
0.03
Bamrasnaradura Infectious Diseases Institute (BIDI), Thailand
1.000000
0.03
Songklanagarind Hospital, Thailand
1.000000
0.03
Srinagarind Hospital, Thailand
1.000000
0.03
Beijing Youan Hospital, China
1.000000
0.03
National Taiwan University Hospital (NTUH), Taiwan
1.000000
0.03
Pusan National University Hospital (PNUH), South Korea
1.000000
0.03
CHA Bundang Medical Center, South Korea
1.000000
0.03
Changi General Hospital, Singapore
1.000000
0.03
Singapore General Hospital (SGH), Singapore
1.000000
0.03
Beijing Friendship Hospital, Capital Medical University, China
1.000000
0.03
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), KMU, Taiwan
0.500000
0.02
Kaohsiung Medical University (KMU), Taiwan
0.500000
0.02
The First Hospital of Jilin University, China
0.500000
0.02
China-Singapore Belt and Road Joint Laboratory on Liver Disease Research, China
0.500000
0.02
Westmead Institute for Medical Research, Australia
0.333333
0.01
The University of Sydney (USYD), Australia
0.333333
0.01
Westmead Hospital (WSLHD), Australia
0.333333
0.01